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You may well wonder why I have combined a 
talk on diabetes in children and adolescents with one 
on diabetic microangiopathy when as pediatricians 
we rarely, if ever, see clinical evidence of the sequelae 
of vascular disease in our patients. If we see protein-
uria in a child, we seek another cause. We may see 
young teen-agers with a microaneurysm or a trace of 
protein, but we soon refer them to our internist 
friends who fall heir to the care of problems that 
doubtless have their beginning in childhood years . 
Pediatricians are, therefore, concerned about these 
problems and the adequacy of treatment they are 
prescribing for their young diabetic patients. 
There is a recent movement to place consid-
erable emphasis again on strict control of blood glu-
cose as a means of reducing complications of diabe-
tes. In an effort to achieve better control rnany 
physicians are placing their patie11ts on two injections 
a day. 
I believe we can say that there are few, if any, 
physicians today who could duplicate Dr. Elliott P. 
Joslin's success in obtaining patient cooperation in 
his efforts to control their diabetes. Yet data from his 
clinic show that only a small percentage achieved 
what he considered excellent control. Nqr did we see 
a striking difference in the incidence of complications 
in his patients when compared with that in the gen-
eral diabetic population. 
I do not minimize the need for achieving as 
nearly optimal control as one can with insulin , but I 
believe a return to the old emphasis on strict control 
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does a disservice to our diabetic children and adoles-
cents . It misleads them into thinking that controlling 
the blood sugar adequately is possible with present 
day methods of insulin administration; that if this is 
achieved, it will prevent or slow down complications; 
and that if this is not achieved, even with the most 
conscientious efforts, it is the patient's fault. I believe 
there is evidence that none of the above is true. A )so, 
this re-emphasis on <;.:ontrol and what it does or does 
not do to the basement membrane, diverts our atten-
tion from pursuing other productive avenues of re-
search that may uncover clues and therapeutic ap-
proaches. It is with some of these avenues that I 
would like to acquaint you and stir your interest. 
I would like first to address myself to important 
considerations in the care of the child or adolescent 
who has diabetes . 
It is , of course, fundamental that the patient and 
the parents be properly educated about diabetes and 
its control at the very beginning if one is to expect 
acceptance and participation in a program of good 
management. We feel this should always be initiated 
on a hospital ward even if the child is not acidotic. 
Here the patient and parents can work with a teach-
ing team in a relaxed setting where questions can 
readily be answered before the family is left on its 
own . The focus of instruction for the very young 
child and infant is both parents; by 7 to 10 years of 
age the child can help with urine testing; the 11-year-
old can learn to give his or her own injections. In the 
teens the patient becomes the focus of instruction 
with parents also learning the facts and techniques. 
Do not be misled on this point: teen-agers very much 
need and want the support of their parents in these 
circumstances. 
As soon as the patient has intravenous feedings 
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discontinued and is ambulatory the routine that he or 
she will continue at home is initiated. After the acid-
osis is cleared the patient is not awakened during the 
night hours for either urine testing or supplemental 
insulin. 
The educational process continues upon dis-
charge from the hospital, first with phone calls to talk 
over changes in insulin dosage, and then in weekly 
visits to the clinic. As confidence and understanding 
increase, visits are less frequent but are continued 
with regularity. 
What do we teach our patients about diabetes 
and how it should be managed? 
Good management of the diabetic begins with 
the physician's smooth management of the initial ke-
toacidotic episode, for actions speak louder than 
words. I believe pediatricians have an advantage here 
because it can be said with certainty, if not with 
modesty, that pediatricians have been in the forefront 
in the proper administration of fluids and electrolytes. 
One need only recall the names of Gamble, Butler, 
and Darrow to know that we have had good mentors. 
Fluids play a most important role in recovery from 
acidosis; no amount of insulin will rid the patient of 
the accumulation of hydrogen ion and restore his or 
her base deficit. Briefly, the initial hydrating solution 
is a mildly hypotonic solution of sodium chloride free 
of potassium, containing bicarbonate if acidosis war-
rants its use. This is followed by a more hypotonic 
solution including potassium and dextrose, usually 
around the second hour. We discourage the use of 
isotonic saline as unphysiologic because of its high 
anion concentration and the absence of free water. 
Pediatricians also for many years have been adminis-
tering small doses of insulin at frequent intervals 
instead of the large doses prescribed in adults. In-
deed, the recent introduction of continuous in-
travenous administration of low levels of insulin has 
little if any advantage over our long-used methods of 
administration. We begin with 0.5 to 1.0 units/ kg 
crystalline insulin, giving half intravenously and half 
deep subcutaneously, Every hour the dose is reduced 
by 50% unless the interval reveals no progress in 
reducing the blood glucose. The previous hour' s dose 
is then repeated. 
After intravenous therapy is discontinued and 
oral feedings initiated, regular insulin is given with 
meals for one or two days. Lente®, a long-acting 
insulin, comprised of 70% Ultralente® and of 30% 
Semilente®, is then given once daily prior to break-
fast. 
Our goal is to allow a trace or 1 + glycosuria in 
urines tested prior to meals and at bedtime. The 
Lente® is increased daily by 2 to 4 units until control 
is achieved. 
We teach the patient to monitor his or her dia-
betic control through daily urine tests: that is, a 
double-voided specimen before breakfast, before sup-
per, and at bedtime. After discharge from the hospi-
tal we allow time for a pattern to develop in response 
to the child's home and school routine. If the glyco-
suria falls to negative levels after discharge as so 
frequently happens, the patient reduces the Lente® 
Insulin by 2 units after a day of negative tests, or by 4 
units if there are symptoms as well. If glycosuria 
increases uniformly before breakfast and before sup-
per, the patient increases it by 2 units every three to 
four days until control is again achieved. If a pattern 
of glycosuria develops in which all the morning 
urines are 3 + to 4 + and the pre-supper urines are O 
to 1 +, the patient increases the Ultralente® or long-
acting portion of the Lente® mixture. Conversely, if 
late afternoon urines are high in sugar, the patient 
increases the short-acting or Semilente® portion. In 
this way we achieve as good control over the 24-hour 
period as with those who use NPH® twice a day and 
avoid the use of two injections. For this reason we 
have abandoned the use of NPH® in favor of the 
Lentes®. As those of you who follow young children 
know very well, there frequently is no pattern to the 
glycosuria, and levels will go from negative to 4+ . 
One may be guided in such circumstances by daily 
urine volumes and adjust the insulin to keep urine 
volumes in the normal range. 
If acetone appears, the patient is to take regular 
insulin at that time. He or she is asked to take 1/ 5 of 
his or her daily dose of Lente® for moderate or large 
and 1/ 10 for small amounts of acetone. This is re-
peated at subsequent testings if acetone persists. 
If the child becomes ill and is unable to eat or is 
vomiting, the Lente® is omitted and small amounts of 
regular insulin are given. Depending on the nature of 
the problem, the child will be seen in the Emergency 
Room; admitted, or followed at home by phone in-
structions. 
The diet we propose for the diabetic is no differ-
ent from one we propose for the non-diabetic. It con-
sists of a good source of protein as the cornerstone of 
the diet, carbohydrate obtained mainly from 
starches, a drastic reduction in refined sweets, a mix-
ture of predominantly unsaturated and saturated 
fats, and, finally , foods containing adequate rough-
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age, minerals, and vitamins. We allow the patient to 
use his appetite as his guide, warning against gorging 
or excessive snacks, and to use his weight-for-height 
gains as a monitor of his progress. If overweight is or 
becomes a problem in the diabetic, he should be 
approached as a youngster, not a diabetic, with a 
weight problem. I see no reason to single out the 
diabetic in his diet therapy when there is no scientific 
data to suggest this approach is any more harmful to 
him than to his non-diabetic peers. 
We do not attempt to make gross changes in a 
patient's lifestyle. We recommend regular exercise for 
all youngsters, but we do not urge all-out vigorous 
athletics if that is not the child's habit. If exercise can 
be anticipated, the morning dose of insulin is re-
duced. If it cannot, increased carbohydrate intake 
during and after the exercise is required. We explain 
to teen-agers the serious effects of smoking on the 
cardiovascular system and urge them not to begin. 
We explain the hazards of drinking and urge care in 
this area if they do indulge. 
There are a number of special problems we see in 
children and adolescents. 
First of all, the term "brittle" diabetic is fre-
quently used to describe the majority of juvenile dia-
betics. I believe this is too broad a use of the term and 
often reflects only a poor understanding of how to 
manage youngsters whose exercise pattern is unpre-
dictable and whose increased needs with growth are 
not properly met. I would reserve the term for the 
juvenile diabetic who is truly difficult to manage; in 
my experience such patients are few in number and 
all have been teen-age girls under severe emotional 
stress. 
In the adolescent years there is both an increase 
in need for insulin and an increase in binding, with 
insulin resistance of variable degree resulting. Re-
quirements can often rise at an alarming rate to needs 
of 140 to 160 units per day. The periods of increased 
need are variable and unpredictable in their length . 
When the total daily dose reaches 90 to I 00 units the 
dosage is split; 2/ 3 is given before breakfast and I / 3 
before supper. It is frequently advisable to admit the 
patient to make these adjustments . We admit the 
teen-ager to the Children's Rehabilitation Center 
where both physical and school activities can be pur-
sued so that home conditions are more nearly simu-
lated than on a hospital ward. A schedule is set up in 
which, again, the patient participates. Pre-meal and 
two-hour post-meal blood glucoses are obtained, 
urine volumes are measured, and caloric estimates of 
the food intake that satisfies the patient's appetite in a 
normal manner are made. Urine volumes are col-
lected in the following manner: patient voids and 
discards at 7 AM ; Urine #1 is voidings up to lunch; 
urine #2 up to dinner; urine #3 up to 9 PM, and urine 
#4 overnite to 7 AM. In this manner grams of glu-
cose/ hour spilled in respect to a meal can be 1::alcu-
lated. Urine volumes collected periodically at home 
give the diabetic another index of his control. 
True insulin resistance is defined rather arbi-
trarily as a requirement that exceeds 200 units per 
day, occurring in the absence of ketosis, infections, or 
other known stresses. The few cases that have oc-
curred in juvenile diabetics have been predominantly 
among teen-agers 14 to 16 years of age. Most are due 
to increased antibody formation and respond either 
to changing to pork insulin, which is less antigenic 
than beef, or to steroid therapy. We have recently 
reported the very rare occurrence of severe resistance 
to insulin in a 17-year-old gi'rl who does not have 
excessive antibodies either to insulin or to her insulin 
receptors and showed no improvement on steroids.' 
She was resistant to as much as 5,000 units in pork 
regular insulin given subcutaneously, but responded 
normally to a continuous 24-hour infusion of insulin 
and was well regulated in 60 to 70 units pet day. After 
5 months of continuous I. V. insulin she remitted 
spontaneously and is presently regulated on 85 units 
Lente® in the morning and 35 units Lente® before 
supper. Since our report, 5 more females of similar 
age with the same problem have come to our atten-
tion. 
Over-treatment with insulin can of course result 
in hypoglycemia, but it can also result in a curious 
and unexplained phenomenon called the Somogyi 
reaction, which usually appears after sudden and ex-
cessive increases in insulin. The reaction is character-
ized by polydipsia and polyuria, sometimes to an 
overwhelming degree. Unlike the patient in acidosis, 
however, the C02 is not elevated though the glucose 
values may be very high. The explanation given by 
Somogyi is that the intense hypoglycemia generated 
by excessive insulin, usually occurring between 2 AM 
and 4 AM, causes a discharge of adrenalin and a swift 
rise in blood glucose to excessive levels. The increased 
glycosuria in the morning and the excessive polyuria 
suggest the need for more insulin, and a vicious circle 
ensues. The patient needs to be hospitalized, taken 
off long-acting insulin, and regulated on regular in-
sulin before returning to Lente®. 
One final problem we encounter, especially in 
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teen-agers, is noncompliance. This must be dealt with 
in a sympathetic yet firm manner. One can only have 
deep feelings of empathy for youths who are strug-
gling to establish their own identity in a world gener-
ally hostile to teen-agers, and who are aware that in 
the not-too-distant future they will be on their own. 
Our approach,2 therefore, is to keep the de-
mands on the patient simple but to work closely with 
him to follow these simple rules: 
1) Double void urine twice a day, test for glu-
cose and acetone, and record results so they 
can be reviewed with the patient. 
2) Take insulin without fail each morning. 
3) Eat a sound diet at regular time intervals and 
in amounts that satisfy appetite and maintain 
normal weight. 
4) Keep regular medical appointments at 3-
month intervals. This provides an opportun-
ity to review the patient's understanding of 
diabetes and its control. 
would now like to turn to a discussion of 
abnormalities in serum proteins, platelets, and red 
blood cells of diabetic subjects discussed at a confer-
ence on Diabetic Microangiopathy held by the Kroc 
Foundation in April, 1976. The conference was ar-
ranged by Dr. Donald McMillan of the Sansum 
Medical Research Foundation and Dr. John Ditzel 
of Aalborg, Denmark, and the papers have appeared 
in the November, 1976 supplement of Diabetes. 3 
The abnormalities I wish to describe may play a 
role in the genesis of diabetic angiopathy or are fac-
tors that reduce tissue delivery of oxygen by hemo-
globin. These mechanisms can lead to tissue hypoxia 
and subsequent tissue damage. 
First, Dr. McMillan, 4 as well as others, describes 
significant increases in serum proteins in diabetics. 
No system of proteins is spared. Studies of newly 
diagnosed diabetics show increases as great as those 
in established diabetics. Abnormalities are independ-
ent of the presence of sequelae of microangiopathy . 
The majority of the proteins elevated in diabetics 
are acute phase reactants: a 1 acid glycoproteins, a1 
antitrypsin, haptoglobin, ceruloplasmin, C-reactive 
protein, C3C, C4 and C3 activator, and fibrinogen. 
Albumin levels are lower than normal. By direct mea-
surement Dr. McMillan has shown that diabetic se-
rum has a greatly increased viscosity which is due to 
the elevation of these proteins. The abnormal vis-
cosity bears no relation to age, sex, body weight or 
duration or type of treatment of the diabetes. 
Erythrocyte aggregation is markedly increased 
due to the increased fibrinogen level as well as to 
increases in other elongated proteins. Increased 
erythrocyte aggregation has the added effect of en-
hancing the coagulation of blood. 
Platelet aggregation is also increased in diabetics 
in the early stages of the disease as well as later. There 
is a greater sensitivity than normal to aggregating 
agents such as adenosine diphosphate (ADP), epi-
nephrine, and collagen. 
At the same time that intravascular factors are 
leading to the occlusion of small blood vessels, the 
fibrinolytic system, the body's defense against vascu-
lar occlusion, is decreased. This abnormality is more 
pronounced m patients with signs of micro-
angiopathy. 
We have recently made observations on red cell 
membranes in diabetics and have noted an abnormal 
adherence of hemoglobin to the red cell membranes. 5 
Red cell ghosts prepared by the method of 
Dodge were solubilized in 1% sodium dodecycl sul-
fate (SOS), separated by gel electrophoresis and 
stained with Coomassie® Blue (Figure). Increased 
amounts of hemoglobin were noted in the mem-
branes of diabetics, B, C, and D, compared to those 
of a non-diabetic child, A. Dislodging the hemoglo-
bin from red cell ghosts with Tris (hydroxymethyl 
aminomethane ), a nonionic buffer, simultaneously 
A B C D E F G H 
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Figure-Membrane proteins of erythrocyte ghosts in I% SDS sepa-
rated by polyacrylamide gel electrophoresis and stained with Coo-
massie"9 Blue. A to D (untreated ghosts): A, normal 12-year-old; B, 
8-year-old on insulin one month; C, top layer of ghosts, pale yellow, 
D, bottom layer, pink , 15-year-old on insulin five years. E and F 
(ghosts extracted with 0.01 M Tris, pH 8.2): E - A; F - B.G to J 
(Tris eluates): G - A, H - C, I - D, and J - B. In D note the 
doublet of band 6 and the heavy band of hemoglobin, and the 
appearance of those components in the Tris eluate. The proteins 
are eluated roughly in proportion to the amount of hemoglobin 
adhering to the membrane. 
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removed both peripheral and integral membrane pro-
teins. E and F represent the ghosts after membrane 
bands 4.1 to 4.5, 5, 6, and 7, as well as the hemoglo-
bin. It is suggested that the tightly adhering and 
increased amounts of hemoglobin on diabetic mem-
branes interfere with normal erythrocyte deformabil-
ity because deformability is influenced by the per-
ipheral proteins of the inner aspect of the red cell 
membrane. Normal deformability is essential for nor-
mal blood flow since the diameter of erythrocytes is 
greater than the diameter of the smallest blood ves-
sels through which they must pass. 
Finally there is evidence of disturbance in oxy-
gen transport in diabetics. Rahbar6 originally de-
scribed the abnormal increases of the minor hemo-
globin components Ala, b, and c in diabetic adults. 
We have made a similar report in children. In spite of 
acceptable control of their diabetes, young children, 
and adults as well, have levels that are twice normal. 
The important fact about hemoglobin Ale is that it 
does not react with 2, 3 diphosphoglycerate (2,3 
DPG), thus reducing the ability of hemoglobin Ale 
to yield oxygen to the tissues. Opposing this impair-
ment of oxygen release due to increased levels of Ale, 
Ditzel has found elevated levels of 2,3 DPG but a 
lower than normal P50• Phosphate administration to 
these diabetic children brought their P50 to the level of 
the normal control group. This may be a therapeutic 
approach toward improving oxygenation of diabetic 
tissue that warrants further study. 0 
The legitimate question can now be raised as to 
whether these intra vascular abnormalities are not due 
solely to insulin · deficiency and therefore simply re-
flect inadequate control of the diabetic state with 
insulin. This may be true. At present we do not know. 
However, in respect to the increases in acute phase 
proteins observed in diabetics, studies of protein syn-
thesis of the perfused rat liver by Miller have revealed 
a very interesting finding. 7 Abnormal alpha cell func-
tion is an integral part of the diabetic state. 8 Gluca-
gon secretion continues during periods of glucose 
plenty and is stimulated by amino acids in the pres-
sure of hyperglycemia. Miller has found that gluca-
gon, either alone or in combination with cortisol, 
stimulates the acute phase proteins including fibrino-
gen. The in vitro effects can be abolished with insulin. 
The possibility thus arises that glucagon excess in a 
setting of insulin deficiency is the initiating factor of 
the sequence of events leading to microvascular oc-
clusion. We have begun a prospective study in our 
young diabetics of the degree of abnormality of 
glucagon secretion and its progression, and the levels 
of acute phase proteins, to determine if a correlation 
exists between them. 
I conclude by paraphrasing a well-known slo-
gan, "We want to find a cure for diabetic micro-
angiopathy before our diabetic children leave adoles-
cence," because success of treatment undoubtedly lies 
in applying it in the trouble-free childhood years. 
The figure is reproduced with permission from Diabetes (25: 
805-930,. 1976). 
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